Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 625.00 | 556.96 | 552.00 | 1048.75 | 0.5263 | -0.0097 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 625.00 | 556.96 | 1060.00 | 1048.75 | 1.0107 | 1.0235 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 625.00 | 556.96 | 1055.00 | 1048.75 | 1.0060 | 1.0131 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 625.00 | 556.96 | 983.00 | 1048.75 | 0.9373 | 0.8631 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 625.00 | 556.96 | 1195.00 | 1048.75 | 1.1395 | 1.3074 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 625.00 | 556.96 | 1155.00 | 1048.75 | 1.1013 | 1.2230 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 625.00 | 556.96 | 986.00 | 1048.75 | 0.9402 | 0.8693 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 625.00 | 556.96 | 1081.00 | 1048.75 | 1.0308 | 1.0675 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 625.00 | 556.96 | 471.00 | 1048.75 | 0.4491 | -0.1677 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 888.00 | 1048.75 | 0.8467 | 0.6668 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1043.00 | 1048.75 | 0.9945 | 0.9880 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 851.00 | 1048.75 | 0.8114 | 0.5909 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 986.00 | 1048.75 | 0.9402 | 0.8693 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 625.00 | 556.96 | 630.00 | 1048.75 | 0.6007 | 0.1445 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 625.00 | 556.96 | 1148.00 | 1048.75 | 1.0946 | 1.2082 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1272.00 | 1048.75 | 1.2129 | 1.4708 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 625.00 | 556.96 | 397.00 | 1048.75 | 0.3786 | -0.3098 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1196.00 | 1048.75 | 1.1404 | 1.3095 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1086.00 | 1048.75 | 1.0355 | 1.0779 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 625.00 | 556.96 | 1259.00 | 1048.75 | 1.2005 | 1.4431 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 625.00 | 556.96 | 1203.00 | 1048.75 | 1.1471 | 1.3243 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 625.00 | 556.96 | 1104.00 | 1048.75 | 1.0527 | 1.1157 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 625.00 | 556.96 | 1123.00 | 1048.75 | 1.0708 | 1.1556 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 625.00 | 556.96 | 1189.00 | 1048.75 | 1.1337 | 1.2947 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1103.00 | 1048.75 | 1.0517 | 1.1136 |